Drafted and prosecuted a ground-breaking small molecule cancer drug developed by a biotechnology start-up company, leading to the acquisition of the patent portfolio by a multi-national pharmaceutical company, and continued representation of the multi-national pharmaceutical company in follow-up patent prosecution to cover intellectual property arising from clinical trials of the small molecule drug.
McCarter & English, LLP | Contents of this website may contain attorney advertising. | Results may vary depending on your particular facts and legal circumstances.